Tak­ing pulse on pri­vate biotech fund­ing; Q&A with Iso­mor­phic Labs CEO; Re­search in­sti­tu­tions re­thinks deal­mak­ing; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

The first edi­tion of Ly­dia Ram­sey Pflanz­er’s brand new newslet­ter, End­points Health Tech, is out! It marks our first for­ay out­side the world of bio­phar­ma, and promis­es to com­ple­ment our cur­rent cov­er­age. Check out the launch note, where Ly­dia lays out her vi­sion and the themes she’s watch­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER